Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical fluorouracil 5% vs niacinamide 1% for actinic keratosis
IRCT20220519054920N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluorouracil and nicotinamide in actinic keratosis (AK) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
fluorouracilnicotinamide
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on IRCT20220519054920N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220519054920N1.